Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| HCC1143 | AZD6738 | 0.00316227766017 | 1.2712 | -0.00863 |
| CAMA-1 | AZD6738 | 0.00316227766017 | 1.2713 | -0.00124 |
| MDA-MB-361 | Ulixertinib | 0.001 | 1.2738 | 0.00488 |
| HCC1395 | Alvocidib | 0.000316227766017 | 1.2746 | 0.00082 |
| MDA-MB-157 | Ulixertinib | 0.001 | 1.2756 | 0.04302 |
| MDA-MB-361 | SHP099 | 3.16227766017 | 1.2780 | 0.03078 |
| HCC1428 | RO-3306 | 1.0 | 1.2785 | -0.03059 |
| HCC1428 | AZD6738 | 0.1 | 1.2785 | -0.00867 |
| SUM1315MO2 | THZ1 | 0.001 | 1.2788 | -0.02255 |
| CAMA-1 | MK 1775 | 0.316227766017 | 1.2801 | 0.00036 |
| MDA-MB-134-VI | Alvocidib | 0.01 | 1.2817 | -0.03052 |
| MDA-MB-157 | AZD6738 | 1.0 | 1.2831 | -0.01898 |
| MDA-MB-134-VI | SHP099 | 0.0316227766017 | 1.2841 | -0.03230 |
| CAL-85-1 | SHP099 | 0.1 | 1.2843 | -0.00641 |
| T47D | AZD6738 | 1.0 | 1.2853 | -0.00308 |
| HCC1937 | AZD6738 | 0.01 | 1.2863 | -0.01516 |
| HCC1937 | GSK2334470 | 0.001 | 1.2863 | -0.01885 |
| HCC1428 | AZD6738 | 0.1 | 1.2866 | 0.00411 |
| HCC1500 | BMS-265246 | 10.0 | 1.2877 | -0.21982 |
| CAMA-1 | MK 1775 | 0.01 | 1.2883 | 0.00123 |
| CAL-85-1 | Ulixertinib | 0.003162278 | 1.2893 | -0.00300 |
| MDA-MB-361 | THZ1 | 0.000316227766017 | 1.2895 | -0.01467 |
| SK-BR-3 | AZD5363 | 0.001 | 1.2904 | -0.01470 |
| MDA-MB-157 | AZD6738 | 0.1 | 1.2905 | -0.04263 |
| MDA-MB-134-VI | SHP099 | 3.16227766017 | 1.2911 | -0.02931 |